ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Vimpat 150 mg, comprimés pelliculés - 56 Tablette(n)
59002014 UCB-Pharma SA
Vimpat 150 mg, comprimés pelliculés28.08.2009
Original28.08.2009
Lacosamide (N03AX18) 
WHO-DDD 
01.07.10.56 Tablette(n)
01.07.10. 
B  
Yes 
IPCI
59.98Yes
    
10 %81.65
7680590020140Synthetika
4293950 
Composition
lacosamidum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum) pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Lacosamidum150 mg
BAG: Active AgentDose
Lacosamidum150 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum) pro Compresso Obducto  
(Rubrum)  
Cellulosum Microcristallinum  
Cellulosum Microcristallinum Silicificatum  
Crospovidonum  
E 171 color.
E 172 color.
Hydroxypropylcellulosum  
Hydroxypropylcellulosum Substitutum Humile  
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus) pellicule
Talcum  
 
Source
Data was imported : 03.07.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home